Reviewing the hot-off-the press publication of PATINA, palbociclib in HER-2 amplified breast cancer along with endocrine therapy and HER-2 targeted antibodies.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
